Skip to main content

Information for Vermont Prescribers of Prescription Drugs (Short Form)

RYBELSUS® (semaglutide) tablets 7 mg or 14 mg

  • This list does not imply that the products on this chart are interchangeable or have the same efficacy or safety. Please refer to each product's FDA-approved label and indication for further information.
  • The prices listed below are Average Wholesale Prices ("AWP") as established and made available to the public by a third-party publisher or as calculated from data made available to the public by a third party publisher. The price paid by consumers may be higher or lower than the prices listed below. Information about AWP of these drugs is being provided to Vermont prescribers pursuant to Vermont law, to give you information about the relative prices of marketed drugs and other drugs in the same therapeutic class.
  • The prices listed here do not necessarily reflect price per dosage, price per course of treatment or the cost effectiveness, of all the products listed. For simplicity, only the smallest package sizes available for each product are included.

Price comparison:

Marketed product and lowest dosage of other products in same therapeutic class.*

Marketed Product Unit Price (AWP)
RYBELSUS® Tab 3 mg $38.74
Other Products Unit Price (AWP)
ADLYXIN® (10MCG OR 20MCG/0.2ML) Non-pill product
BYDUREON® (2MG) Non-pill product
BYDUREON BCise® (2MG/.85ML) Non-pill product
BYETTA® (5MCG/0.02ML) Non-pill product
OZEMPIC® (.25MG OR .5MG/DOSE) Non-pill product
SAXENDA® (18MG/3ML) Non-pill product
SOLIQUA 100/33® (100-33 UNT-MCG/ML) Non-pill product
TRULICITY® (.75MG/.5ML) Non-pill product
VICTOZA® (18MG/3ML) Non-pill product
XULTOPHY 100/3.6® (100-3.6 UNIT-MG/ML) Non-pill product

*Prices shown are for the lowest dosage of each product. 

For additional price comparison information see: http://www.novopricing.com/rybelsus-long.html